Targeting Microcirculation to Establish a New System for Cancer Prevention, Treatment, and Rehabilitation
April 15-21, 2026 marks the 30th National Cancer Prevention Awareness Week, with this year's theme focusing on "Comprehensive Cancer Prevention Action for All Populations, All Cycles, and the Whole Society." As medical understanding of tumors deepens, microcirculation has moved from behind the scenes to center stage, confirmed as the core hub for tumor initiation, development, and metastasis, and a key target for modern precision cancer prevention and treatment. While traditional drugs, surgery, radiotherapy, and chemotherapy face bottlenecks, physical intervention technologies represented by Pulsed Magnetic Microcirculation Therapy are pioneering new pathways for cancer prevention, adjuvant treatment, and rehabilitation management, leveraging their unique advantages of repairing microcirculation and remodeling the tumor microenvironment.
Microcirculation Dysfunction: The "Hidden Hotbed" for Tumor Growth
As the "last mile" for material exchange in the human body, the imbalance in microcirculation homeostasis is a significant trigger and accelerator for tumor development. Clinical research confirms that chronic microcirculation dysfunction constructs a pathological microenvironment conducive to tumor cell survival, proliferation, and invasion, creating a vicious cycle of "dysfunction → cancerous transformation → worsening."
Hypoxia and metabolic disorders drive tumor malignant transformation. Microcirculatory stasis leads to chronic local tissue hypoxia, triggering the "Warburg effect" in tumor cells-whereby they prioritize glycolysis for energy production even in oxygen-rich environments, resulting in the accumulation of large amounts of lactate. The acidic microenvironment not only directly damages DNA and induces genetic mutations but also suppresses immune cell activity, allowing tumor cells to evade immune surveillance.
Immunosuppression: Undermining the Body's Anti-Cancer Defenses Lactic acid, via GPR81/GPR132 receptors, promotes the polarization of macrophages toward the pro-tumor M2 phenotype. Simultaneously, it upregulates PD-L1 expression on tumor cells, reinforcing the "immune brake" against T cells and inactivating NK cells and lymphocytes. This creates an "immune desert," allowing tumors to grow unchecked.
Matrix Remodeling: Opening the "Channel" for Metastasis Abnormal microcirculation activates cancer-associated fibroblasts (CAFs), which secrete large amounts of matrix metalloproteinases (MMPs). These enzymes degrade the extracellular matrix and disrupt tissue barriers, clearing the path for tumor cell infiltration, vascular invasion, and distant metastasis.
Targeting the Microcirculation: A Core Strategy for Cancer Prevention and Treatment
"To treat tumors, one must first treat the blood; unblocking blood vessels prevents cancer." Improving microcirculation and correcting microenvironmental disorders are not only the core focus of primary cancer prevention but also key targets for clinical treatment, forming a multidimensional intervention system.
Anti-angiogenesis: Cutting off the tumor's "lifeline," anti-VEGF targeted therapies-such as bevacizumab-inhibit tumor growth by blocking the formation of new blood vessels. These drugs are widely used in the treatment of lung cancer, colorectal cancer, and other cancers, but they carry risks of drug resistance and bleeding.
Metabolic Regulation: Reversing immune suppression, reducing lactate levels, and correcting an acidic environment can restore T-cell and immune cell function, significantly enhancing the efficacy of PD-1/PD-L1 immune checkpoint inhibitors, and has emerged as a new direction in combination cancer therapy.
Traditional Interventions: Synergy of Medications and Lifestyle Changes Traditional Chinese medicines such as Salvia miltiorrhiza and Ligusticum chuanxiong, which promote blood circulation and dispel blood stasis, as well as Western medications like aspirin and metformin, have all been proven to improve microcirculation and reduce tumor risk. Regular exercise accelerates lactate clearance and improves blood flow, while managing "the three highs" (high blood pressure, high blood sugar, and high cholesterol) helps maintain vascular health, thereby reducing tumor risk factors at the source.
Pulsed Magnetic Therapy: A New Approach to Microcirculation-Based Cancer Prevention
Pulsed Magnetic Microcirculation Therapy (PMR), as a non-invasive physical intervention, leverages three core technologies: cell membrane potential regulation, biomimetic pulsed magnetic resonance, and extremely low-frequency electromagnetic delivery. By emitting specific extremely low-frequency pulsed electromagnetic fields, it repairs microcirculation at the cellular level, providing a safe, effective, and sustainable new method for cancer prevention and treatment.
The core mechanism of pulsed magnetic microcirculation therapy is to repair microcirculation at the cellular level.
Regulation of membrane potential: By modulating ion channels in the cell membrane, this therapy restores the transmembrane movement of ions such as sodium, potassium, and calcium; corrects membrane potential disturbances; enhances cellular permeability and activity; and improves blood rheological parameters.
Dilating microvessels: Promotes the functional repair of vascular endothelial cells, relieves vasospasm, accelerates blood flow, increases tissue oxygenation, reverses local hypoxia, and inhibits the "Warburg effect."
Clearing metabolic waste: Accelerates the elimination of lactate and inflammatory factors, corrects the acidic microenvironment, reduces immunosuppression, and activates the body's antitumor immune response.
Inhibits abnormal angiogenesis: Blocks tumor microvascular proliferation, cuts off nutrient supply, and inhibits tumor growth and metastasis.
Induces tumor cell apoptosis: Alters the charge distribution on tumor cell membranes, interferes with mitosis, and inhibits proliferation, while simultaneously activating the p38MAPK pathway to promote apoptosis.
Pulsed magnetic microcirculation therapy offers multifaceted benefits in cancer prevention and treatment.
Prevention: Regular interventions can improve systemic microcirculation, scavenge free radicals, reduce blood viscosity, and control chronic inflammation, thereby lowering the risk of tumors induced by "three highs" (high blood pressure, high blood sugar, and high cholesterol) and microcirculatory disorders.
Treatment: Works synergistically with surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy to enhance tumor cell sensitivity to drugs, mitigate damage from radiation and chemotherapy, alleviate adverse reactions such as fatigue, pain, and edema, and improve treatment efficacy and tolerability.
Rehabilitation: Accelerates postoperative tissue repair, improves lymphatic drainage, prevents thrombosis and complications, regulates immune function, reduces the risk of recurrence and metastasis, and enhances quality of life.
Full-Cycle Care: Establishing a New Microcirculation-Based Cancer Prevention System
Cancer prevention and treatment is a full-cycle systemic endeavor. With its advantages of being non-invasive, safe, free of side effects, and suitable for bedside use, pulsed magnetic microcirculation therapy can be applied throughout the entire "prevention-treatment-rehabilitation" process, complementing traditional approaches.
Prevention: Regular interventions for healthy individuals and high-risk groups (those with a family history, chronic diseases, or unhealthy lifestyles) to maintain vascular health, improve metabolism, and reduce the risk of cancer.
Clinical Synergy: Improve microcirculation, reduce bleeding and infection during the perioperative period; enhance sensitivity to and reduce toxicity of radiotherapy and chemotherapy; alleviate symptoms and prolong survival during palliative care for advanced-stage patients.
Rehabilitation Management: Long-term interventions following surgery or treatment to restore the microenvironment, boost immunity, and prevent recurrence and metastasis.